Purple Biotech Ltd ADR (PPBT): Next-Year EPS Estimate 83.43%
As of 2026-06-11, Purple Biotech Ltd ADR (PPBT) has a next-year EPS growth estimate of 83.43%.
On 2026-05-18, analyst consensus for PPBT's next-year EPS growth shifted from 61.21% to 83.43% — a positive change of 22.22 percentage points. The revised estimate has been sustained across 19 subsequent trading sessions. Current-year growth is projected at 90.34%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 83.43%
- EPS growth this year
- 90.34%
- EPS next quarter (est)
- -$0.98
- Last price
- $1.54
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 83.43% | 90.34% | -$0.98 | $1.54 |
| 2026-06-10 | 83.43% | 90.34% | -$0.98 | $2.96 |
| 2026-06-09 | 83.43% | 90.34% | -$0.98 | $2.99 |
| 2026-06-08 | 83.43% | 90.34% | -$0.98 | $2.92 |
| 2026-06-07 | 83.43% | 90.34% | -$0.98 | $2.97 |
| 2026-06-04 | 83.43% | 90.34% | -$0.98 | $3.09 |
| 2026-06-03 | 83.43% | 90.34% | -$0.98 | $2.95 |
| 2026-06-02 | 83.43% | 90.34% | -$0.98 | $3.01 |
| 2026-06-01 | 83.43% | 90.34% | -$0.98 | $2.99 |
| 2026-05-31 | 83.43% | 90.34% | -$0.98 | $2.99 |
| 2026-05-28 | 83.43% | 90.34% | -$0.98 | $2.81 |
| 2026-05-27 | 83.43% | 90.34% | -$0.98 | $2.98 |
| 2026-05-26 | 83.43% | 90.34% | -$0.98 | $2.90 |
| 2026-05-25 | 83.43% | 90.34% | -$0.98 | $2.88 |
| 2026-05-24 | 83.43% | 90.34% | -$0.98 | $2.88 |
| 2026-05-21 | 83.43% | 90.34% | -$0.98 | $2.70 |
| 2026-05-20 | 83.43% | 90.34% | -$0.98 | $2.98 |
| 2026-05-19 | 83.43% | 90.34% | -$0.98 | $3.51 |
| 2026-05-18 | 83.43% | 90.34% | -$0.98 | $3.78 |
| 2026-05-17 | 61.21% | 97.00% | -$0.40 | $3.94 |
| 2026-05-14 | 61.21% | 97.00% | -$0.38 | $3.69 |
| 2026-05-13 | 61.21% | 97.00% | -$0.38 | $3.80 |
| 2026-05-12 | 61.21% | 97.00% | -$0.38 | $3.85 |
| 2026-05-11 | 61.21% | 97.00% | -$0.38 | $4.06 |
| 2026-05-10 | 61.21% | 97.00% | -$0.38 | $4.12 |
| 2026-05-07 | 61.21% | 97.00% | -$0.38 | $3.91 |
| 2026-05-06 | 61.21% | 97.00% | -$0.38 | $4.16 |
| 2026-05-05 | 61.21% | 97.00% | -$0.38 | $4.22 |
| 2026-05-04 | 61.21% | 97.00% | -$0.38 | $4.22 |
| 2026-05-03 | 61.21% | 97.00% | -$0.38 | $4.20 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Purple Biotech Ltd ADR's next-year EPS growth estimate?▾
As of 2026-06-11, Purple Biotech Ltd ADR (PPBT) has a next-year EPS growth estimate of 83.43%, based on analyst consensus.
When was the latest EPS estimate revision for PPBT?▾
The most recent revision occurred on 2026-05-18, when analysts adjusted the next-year EPS growth estimate from 61.21% to 83.43%.
What sector and industry does Purple Biotech Ltd ADR belong to?▾
Purple Biotech Ltd ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PPBT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Purple Biotech Ltd ADR (PPBT) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports